title: Hemorrhagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia.
authors.forename: A
authors.initials: A
authors.lastname: Azzi
authors.forename: S
authors.initials: S
authors.lastname: Ciappi
authors.forename: R
authors.initials: R
authors.lastname: De Santis
authors.forename: R
authors.initials: R
authors.lastname: Fanci
authors.forename: F
authors.initials: F
authors.lastname: Leoni
authors.forename: S
authors.initials: S
authors.lastname: Colli
authors.forename: P L
authors.initials: PL
authors.lastname: Rossi-Ferrini
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D001739:BK Virus; D003520:Cyclophosphamide / Q000009:adverse effects; D003556:Cystitis / Q000209:etiology* / Q000382:microbiology; D003561:Cytarabine / Q000009:adverse effects; D006470:Hemorrhage; D006801:Humans; D016867:Immunocompromised Host; D015080:Mesna / Q000627:therapeutic use; D030361:Papillomavirus Infections / Q000150:complications* / Q000276:immunology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy; D011241:Prednisone / Q000009:adverse effects; D014412:Tumor Virus Infections / Q000150:complications*; D014750:Vincristine / Q000009:adverse effects
chemical_list: D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D015080:Mesna; D011241:Prednisone